Nu-Pharm Inc. v. Canada, 2008 FCA 227 (2008)
Linked as:
Extract
Nu-Pharm Inc. v. Canada, 2008 FCA 227 (2008)
Date: 20080703
Docket: A-486-07Citation: 2008 FCA 227CORAM: LINDEN J.A.NADON J.A.SEXTON J.A.BETWEEN:NU-PHARM INC.AppellantandHER MAJESTY THE QUEEN IN RIGHT OF CANADA ,THE ATTORNEY GENERAL OF CANADA , and THE DIRECTORGENERAL, THERAPEUTIC PRODUCTS DIRECTORATE OFHEALTH CANADARespondent sHeard at Toronto, Ontario , on May 26, 2008.Judgment delivered at Ottawa, Ontario , on Ju ly 3, 2008.REASONS FOR JUDGMENT BY: NADON J.A.CONCURRED IN BY: LINDEN J.A.SEXTON J.A.Date: 20080703Docket: A-486-07Citation: 2008 FCA 227CORAM: LINDEN J.A.NADON J.A.SEXTON J.A.BETWEEN:NU-PHARM INC.Appellant(s)andHER MAJESTY THE QUEEN IN RIGHT OF CANADA ,THE ATTORNEY GENERAL OF CANADA , and THE DIRECTORGENERAL, THERAPEUTIC PRODUCTS DIRECTORATE OFHEALTH CANADARespondentsREASONS FOR JUDGMENTNADON J.A.[1] This is an appeal from a decision of Hugessen J. of the Federal Court in Nu-Pharm Inc. v. Canada , 2007 FC 977, who, on a motion for summary judgment, dismissed the appellant’s (the “appellant” or “Nu-Pharm”) action for damages on the ground that the action did not raise a genuine issue for trial.[2] More particularly, relying on this Court’s decision in Grenier v. Canada , 2005 FCA 348, [2006] 2 F.C. 287 (CA), Hugessen J. concluded that since the relief sought by the appellant in its action was contingent upon a determination by the Federal Court that decisions made by the Director General of the Therapeutic Products Directorate of Health Canada (the “Director General”) were unlawful and that such a determination could only be made if the decisions were challenged by way of a judicial review application, it necessarily followed that the appellant’s action could not possibly succeed without such a prior determination. This led the learned Judge to make the following Order:THIS COURT ORDERS that1. The motion is allowed and the action is dismissed.2. Paragraph 1 of the present Order is stayed for a period of 30 days to allow the pl...See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex Canada
Explore vLex
For Professionals
For Partners
Company